Prospective trials on anemia of chronic disease:: The Trial to Reduce Cardiovascular Events with Aranesp® Therapy (TREAT)

被引：16

作者：

Rao, M ^{[1
]}

Pereira, BJG ^{[1
]}

机构：

[1] Tufts Univ New England Med Ctr, Boston, MA 02111 USA

来源：

KIDNEY INTERNATIONAL | 2003年 / 64卷

关键词：

kidney disease; Aranesp (R); renal replacement therapy; rHuEPO;

D O I：

10.1046/j.1523-1755.64.s87.21.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S12 / S19

页数：8

共 77 条

[61] Cardiovascular effects of recombinant human erythropoietin in predialysis patients [J].

Portoles, J ;

Torralbo, A ;

Martin, P ;

Rodrigo, J ;

Herrero, JA ;

Barrientos, A .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (04) :541-548

[62] The beneficial effects of intervention in early renal disease [J].

Portolés, J .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 :12-15

[63] Electrocardiographic left ventricular hypertrophy in renal transplant recipients: Prognostic value and impact of blood pressure and anemia [J].

Rigatto, C ;

Foley, R ;

Jeffery, J ;

Negrijn, C ;

Tribula, C ;

Parfrey, P .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :462-468

[64]

Rigatto C, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341084

[65]

Ritz E, 1996, NEPHROL DIAL TRANSPL, V11, P38

[66] End-stage renal failure in type 2 diabetes:: A medical catastrophe of worldwide dimensions [J].

Ritz, E ;

Rychlík, I ;

Locatelli, F ;

Halimi, S .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) :795-808

[67]

SILBERBERG J, 1990, CAN J CARDIOL, V6, P1

[68] Traditional cardiac risk factors in individuals with chronic kidney disease [J].

Uhlig, K ;

Levey, AS ;

Sarnak, MJ .

SEMINARS IN DIALYSIS, 2003, 16 (02) :118-127

[69]

*UK PROSP DIAB STU, LANCET, V352, P837

[70]

*US REN DAT SYST A, 2000, ATL END STAG REN DIS

← 1 2 3 4 5 6 7 8 →